EUSA Pharma bags US approval for COVID-19 trial

2nd July 2020 Uncategorised 0

Siltuximab is a monoclonal antibody that directly neutralises interleukin (IL)-6, an inflammatory cytokine

More: EUSA Pharma bags US approval for COVID-19 trial
Source: News